Microbot Medical Inc.

Item 7.01 Regulation FD Disclosure. On August 11, 2026, Microbot Medical Inc. (the “Company”) disseminated a press release announcing that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, and providing highlights of the Company’s second quarter ended June 30, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including the attached exhibit, is being furnished, and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language of such filing. By furnishing the information in this Current Report on Form 8-K (“Form 8-K”) and the attached exhibit, the Company is making no admission as to the materiality of any information in this Form 8-K or the exhibit. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description Number ────────────────────────────────────────────────────────────────────────────────────── 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)